Cargando…
Multi‐omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID‐19
Growing evidence has shown that Transmembrane Serine Protease 2 (TMPRSS2) not only contributes to the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, but is also closely associated with the incidence and progression of tumours. However, the correlation of coronavirus disease...
Autores principales: | Liu, Li, Qin, Ju‐Fang, Zuo, Man‐Zhen, Zhou, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817140/ https://www.ncbi.nlm.nih.gov/pubmed/34951103 http://dx.doi.org/10.1111/jcmm.17090 |
Ejemplares similares
-
TMPRSS4: an emerging potential therapeutic target in cancer
por: de Aberasturi, A L, et al.
Publicado: (2015) -
Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer
por: Tazawa, Hirofumi, et al.
Publicado: (2021) -
TMPRSS2: Potential Biomarker for COVID‐19 Outcomes
por: Strope, Jonathan D., et al.
Publicado: (2020) -
TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
por: Ganz, Tomas, et al.
Publicado: (2023) -
TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer
por: Kim, Semi
Publicado: (2023)